Natural Killer and Lymphokine Activated Killer Cell Functions in Hodgkin's Disease
Author Information
Author(s): N. Rajaram, R.J. Tatake, S.H. Advani, S.G. Gangal
Primary Institution: Cancer Research Institute; Tata Memorial Centre
Hypothesis
The study investigates the activities of natural killer (NK) and lymphokine activated killer (LAK) cells in patients with Hodgkin's disease compared to healthy donors.
Conclusion
The study found that while most Hodgkin's disease patients had normal NK activity, those with lymphocyte depletion and clinical stage IV had decreased NK activity, but LAK activity remained efficient.
Supporting Evidence
- 75% of Hodgkin's disease patients had normal NK activity.
- Low NK responders were more common in patients with lymphocyte depletion and clinical stage IV.
- LAK activity was efficient against various tumor targets in both low and normal NK responder patients.
Takeaway
Doctors looked at how certain immune cells work in people with Hodgkin's disease and found that most had normal immune cell activity, but some with more severe disease had lower activity.
Methodology
Peripheral blood lymphocytes from 65 untreated Hodgkin's disease patients and 36 healthy donors were analyzed for NK and LAK cell activities using cytotoxicity assays and limiting dilution analysis.
Limitations
The study had a small number of patients in certain categories, limiting definitive conclusions about correlations between NK activity and disease progression.
Participant Demographics
Patients aged 12-46 years and healthy donors aged 20-50 years.
Want to read the original?
Access the complete publication on the publisher's website